908 Devices reports Q4 EPS (56c), consensus (35c)

Reports Q4 revenue $18.82M, consensus $17.05M. “Today marks a transformative milestone for 908 Devices (MASS)-one that sharpens our strategic focus, enhances margins, and significantly accelerates our path to profitability, bringing our Adjusted EBITDA crossover into this year,” said Kevin Knopp, CEO and co-founder. “We’ve nearly doubled our cash reserves and aligned our efforts with powerful secular trends, including the fentanyl and opioid crisis, the global rise in defense budgets, and the U.S. border crisis. Moreover, our three key growth catalysts position us to exceed 20% top-line growth in 2026, driving full-year cash flow positivity. We believe our actions have fortified 908 Devices and created a compelling go-forward thesis for our investors.”